Inflammation

Homocysteine

A checkpoint in the middle of a pathway, and one of the few functional markers on a standard order form.

Homocysteine is an amino acid produced during methionine metabolism and cleared by a pathway that requires vitamin B12, folate and B6. A raised level, generally above about 15 micromoles per litre by lab standards or above 8 to 9 by functional targets, indicates that clearance pathway is short of a cofactor. It is a useful functional read on B vitamin status, though randomised trials show lowering it with B vitamins does not reduce heart attack or all-cause mortality.

What it actually measures

Most blood markers measure a thing. Homocysteine measures a traffic jam.

Here is how it works. Your body constantly runs a process called methylation, which is the business of attaching small chemical tags to things in order to switch them on or off. It builds neurotransmitters this way. It maintains DNA this way. It processes hormones this way. It is running in you right now, billions of times a second.

In the middle of that cycle sits homocysteine. It is an intermediate, a halfway product, and the body has two routes to clear it. One recycles it back into methionine, and that route needs vitamin B12 and folate. The other converts it onward toward cysteine, and that route needs vitamin B6.

So when homocysteine builds up in your blood, it usually is not because you are making too much. It is because the exits are short of what they need to work.

That is what makes this marker unusual and genuinely useful. A serum B12 tells you how much B12 is floating in your blood. Homocysteine tells you whether the pathway that depends on B12 is actually running. Those are different questions, and the second one is closer to what you actually wanted to know.

Normal and optimal are different questions

Your lab probably draws its line somewhere between 12 and 15 micromoles per litre. Practitioners who use this marker functionally aim for under 8 or 9.

That gap is not arbitrary and it is not just wellness enthusiasm either. The reference range is built from a population, and the population in question includes a great many people whose B vitamin intake is unremarkable rather than good. So the upper end of normal is describing what is common, not what is well supplied.

The functional argument runs like this: homocysteine is a checkpoint, and a checkpoint sitting high means a cofactor is short. A cofactor being short is worth knowing about whether or not the checkpoint value itself causes any harm.

That is the reasoning I find defensible, and I want to be precise about what it does and does not claim, because the next section is where most writing on this marker goes further than it should.

What lowering it does, and what it does not

Alright. This is the part where I have to tell you something that reframes the marker, so listen close.

For years homocysteine was one of the great hopes in cardiovascular prevention. The observational evidence was consistent: people with higher homocysteine had more cardiovascular disease. The mechanism was plausible. B vitamins lower homocysteine cheaply and safely. So a whole generation of large randomised trials went out to test whether lowering it lowered events.

In 2017 Cochrane pooled that work. Fifteen randomised controlled trials, 71,422 participants, follow-up running from one year to more than seven, nine of the fifteen trials at low risk of bias.

The result: no difference against placebo for myocardial infarction, 7.1 percent versus 6.0 percent. No difference for death from any cause, 11.7 percent versus 12.3 percent. Both rated high-quality evidence.

There was one positive finding, and it deserves reporting as carefully as the negative ones. Stroke came out lower on homocysteine-lowering treatment, 4.3 percent versus 5.1 percent, a relative risk of 0.90, also high-quality evidence. Real, small, and consistent.

So what do you do with that? Two things, and they point in opposite directions from where most people land.

First, stop treating a homocysteine number as a heart attack lever. It is not one. The trials that would have shown that were run properly and at scale, and they did not show it.

Second, do not throw the marker away, because the trials answered a question about treatment and not a question about diagnosis. The trials gave B vitamins to large mixed populations, most of whom were not deficient, and asked whether events fell. That is not the same as measuring homocysteine in one person to find out whether their methylation pathway has what it needs.

The number is still telling you something true about your B vitamin status. It was just never the cardiovascular lever it was sold as, and the honest thing is to say so on the page rather than quietly leave the impression standing.

What moves it

Down: correcting a genuine shortfall in B12, folate or B6, which is the main lever. Riboflavin and betaine, which feed the same pathway. Treating hypothyroidism, since thyroid function affects it. Reducing heavy alcohol intake and stopping smoking. Adequate folate intake also blunts the effect of the common MTHFR variants.

Up: shortfalls in B12, folate or B6. Reduced kidney function, which is one of the strongest non-nutritional drivers and a reason a high value deserves a proper look. Hypothyroidism. Some medications, including metformin and methotrexate. Heavy alcohol, smoking, and increasing age. Two copies of a less efficient MTHFR variant, particularly on a low folate intake.

The honest hedge

I am not a doctor and I am not diagnosing anyone.

This is the marker where I most want you to hold two things at once. A raised homocysteine is genuinely useful information about your B vitamin status, and it is not a number to treat as a target for its own sake. Both of those are true and the second one comes from good trial evidence rather than from caution.

There is a specific practical caution here too, and it is not decorative. High dose folic acid can lower homocysteine while a B12 shortfall continues underneath, and a 2024 review in Food and Nutrition Bulletin worked through the clinical evidence that excess folic acid can exacerbate B12 deficiency and mask it. B12 deficiency left running causes neurological damage that does not always reverse. So the order matters: test B12 and folate, then correct what is actually short, rather than reaching for a high dose B complex because a number looked high.

A markedly raised homocysteine is also a reason to have kidney function checked, which is a doctor conversation rather than a supplement one.

I am not saying your methylation is broken. I am saying it is a variable, a measurable one, and one that almost nobody has ever had ordered.

So. What to actually do.

Tonight, at no cost. Look through your last blood work for the word homocysteine. It is almost certainly not there, which means the functional question has never been asked.

Test it alongside the vitamins rather than instead of them. A B12 and folate panel tells you what is in circulation. Homocysteine tells you whether the pathway depending on them is running. Together they answer a question neither can answer alone.

Draw it fasted. Homocysteine rises after a protein-containing meal, and the sample needs handling reasonably promptly, so use a lab that runs it routinely.

If it comes back high, work the list rather than the number. B12, folate, B6, thyroid, kidney function, alcohol. That is a conversation for a good functional medicine doctor, and it is a far better use of a high result than buying a methylation supplement.

Recheck in about three months. This is one of the more responsive markers, and if it has not moved on adequate B vitamins, that itself is the finding.

None of this has to happen this week. But tonight you can check whether anyone ever measured the pathway rather than just the vitamin.

You are not tired because your body forgot how to work. You are a cycle with cofactors, running billions of times a second, occasionally short of one small thing at one specific step.

Your body is not broken. It is blocked. And sometimes the block is a single missing cofactor at a junction nobody ever measured, quietly backing up a pathway that touches your mood, your DNA and your hormones all at once.

Go find out whether the pathway has what it needs.

Read these alongside it

Vitamin B12

One of the two cofactors on the recycling route.

Folate

The other one, and the one most easily mistaken for the whole answer.

hs-CRP

The other inflammation-adjacent marker worth having alongside.

B12 and folate panel

Both cofactors measured in one draw.

Brain fog

Methylation and B vitamins are one of the threads worth pulling.

Know what your numbers mean

Occasional notes on the markers worth measuring, what the research supports, and where it stops. No hype, and you can leave any time.

The gift arrives by email, so the box has to stay ticked to send it. After that you get what Jess is actually testing that week, and one click stops it forever.

Questions

What is a normal homocysteine level?
Most labs report a reference range of roughly 5 to 15 micromoles per litre, and some use an upper limit closer to 12. As with many markers built from population data, the top of that range includes a lot of people whose B vitamin status is not where anyone would want it, which is why the functional target sits lower than the lab cutoff.
What is an optimal homocysteine level?
Practitioners who work with this marker generally aim for under 8 to 9 micromoles per litre, on the reasoning that homocysteine is a checkpoint rather than a destination and a lower value indicates the methylation pathway is running with adequate cofactors. That is a functional target from practitioner consensus, and it is worth knowing that lowering the number has a more complicated relationship with hard outcomes than the target implies.
Is a homocysteine of 14 high?
It is inside most lab reference ranges and above the functional target most root-cause practitioners use, which puts it in the zone worth understanding rather than the zone worth panicking about. The more useful next step than debating the cutoff is asking why: B12, folate and B6 status, kidney function, thyroid function and genetics all feed into it, and those are answerable questions.
What does high homocysteine mean?
Most commonly it means the methylation pathway that clears homocysteine is short of a cofactor, and the usual suspects are B12, folate and B6. Beyond nutrients, reduced kidney function raises it substantially, hypothyroidism raises it, some medications including metformin and methotrexate raise it, and heavy alcohol and smoking contribute. A markedly raised value belongs in front of a doctor rather than a supplement shelf.
How do I lower my homocysteine?
Correcting the B vitamin shortfalls that drive it is the direct route, meaning B12, folate and B6 with the specific one guided by testing rather than a blanket high-dose combination. Riboflavin and betaine also feed the pathway. Addressing the non-nutritional drivers matters just as much: kidney function, thyroid function, alcohol and smoking. Because B12 and folate interact in ways that can mask each other, testing before supplementing is the sensible order.
How long does it take to lower homocysteine?
When a genuine B vitamin shortfall is being corrected, homocysteine typically responds within about four to twelve weeks, which makes it one of the more satisfying markers to recheck. If it does not move on adequate B vitamin repletion, that is useful information in itself and usually points toward kidney function, thyroid or something else driving it.
Which test measures homocysteine?
A plasma total homocysteine test, usually drawn fasting because levels rise after a protein-containing meal. Handling matters more than for most tests, since the sample needs to be separated reasonably promptly or the value drifts upward artificially, so it is worth using a lab that runs it routinely.
Is homocysteine on a standard blood panel?
No. It has to be requested specifically, and it is not part of a standard annual draw or a standard lipid panel. That is one reason a B12 or folate shortfall can run for a long time without anything flagging, since the marker that would have shown the functional consequence was never ordered.
Does lowering homocysteine reduce heart attack risk?
This is where honesty matters more than enthusiasm. A 2017 Cochrane review of 15 randomised trials covering 71,422 participants found no difference between homocysteine-lowering B vitamin supplementation and placebo for myocardial infarction or death from any cause, rated as high-quality evidence. The same review did find a small reduction in stroke, with 4.3 percent versus 5.1 percent and a relative risk of 0.90. So the honest summary is that raised homocysteine is associated with cardiovascular risk, and lowering it with B vitamins has not produced the heart attack benefit that association suggested.
Why is homocysteine still worth measuring then?
Because it answers a different question than the one those trials asked. Homocysteine is a functional read on whether your methylation pathway has the cofactors it needs, so a raised value points at B12, folate or B6 status in a way a serum level alone sometimes misses. Testing it to understand your B vitamin status is a well founded use. Treating the number itself as a lever to pull for heart attack prevention is what the trial evidence does not support.
What is the MTHFR connection to homocysteine?
MTHFR codes for an enzyme that converts folate into the form the methylation pathway actually uses, and common variants reduce that enzyme's efficiency. People carrying two copies of the less efficient variant tend to run higher homocysteine, particularly when folate intake is low. Worth keeping in proportion: these variants are extremely common, adequate folate intake largely compensates, and homocysteine itself is the more informative test since it measures the outcome rather than the predisposition.
Should homocysteine be tested with B12 and folate?
Yes, and that combination is where the real value sits. Serum B12 in particular can read normal while function is already compromised, and homocysteine is one of the functional markers that reveals that gap. Running the three together tells you both what is in circulation and whether the pathway that depends on it is actually working.

References

  1. Marti-Carvajal AJ, et al. Homocysteine-lowering interventions for preventing cardiovascular events. The Cochrane Database of Systematic Reviews. 2017. PMID 28816346
  2. Langan RC, Goodbred AJ. Vitamin B12 Deficiency: Recognition and Management. American Family Physician. 2017;96(6):384-389. PMID 28925645
  3. Miller JW. Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications? Food and Nutrition Bulletin. 2024. PMID 38987872